Page last updated: 2024-10-31

midazolam and Metabolic Diseases

midazolam has been researched along with Metabolic Diseases in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Figurska, M1
PÅ‚ocnarska, E1
Stankiewicz, A1
Rybicki, Z1
Rekas, M1

Other Studies

1 other study available for midazolam and Metabolic Diseases

ArticleYear
[Monitoring of blood pressure during phacotrabeculectomy].
    Klinika oczna, 2004, Volume: 106, Issue:1-2 Suppl

    Topics: Aged; Aged, 80 and over; Anesthetics, Intravenous; Blood Pressure; Blood Pressure Determination; Car

2004